(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI ...
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions ...
Magnetic resonance imaging (MRI) contrast agents have had a significant impact on the value of MRI by enhancing the visibility of internal bodily structures such as organs and vasculature. MRI ...
Contrast materials can help highlight areas of interest in MRI scans. Contrast injections may cause side effects like mild rashes and hives, but, in rare instances, it is also possible for a person to ...
Scientists believe they may have found the reason why some patients get so sick from the contrast dye they’re injected with before magnetic resonance imaging (MRI) scans. While researchers have long ...
CHICAGO--(BUSINESS WIRE)--The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) today announced an educational partnership to help train sonographers to perform ...
Biparametric MRI, which omits dynamic contrast-enhanced sequences, similarly detected clinically significant prostate cancer to multiparametric MRI. Biparametric MRI was also noninferior to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback